Foghorn Therapeutics Inc.
FHTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$87 | -$98 | -$109 | -$101 |
| Dep. & Amort. | $3 | $3 | $8 | $3 |
| Deferred Tax | $0 | $0 | $0 | $1 |
| Stock-Based Comp. | $12 | $16 | $0 | $8 |
| Change in WC | -$32 | -$42 | $282 | $33 |
| Other Non-Cash | $3 | $3 | $13 | $5 |
| Operating Cash Flow | -$100 | -$118 | $194 | -$50 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$1 | -$3 |
| Net Acquisitions | $0 | $0 | $0 | -$39 |
| Inv. Purchases | -$261 | -$74 | -$409 | -$100 |
| Inv. Sales/Matur. | $232 | $220 | $166 | $139 |
| Other Inv. Act. | $0 | $0 | $0 | $39 |
| Investing Cash Flow | -$30 | $144 | -$244 | $36 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$21 |
| Stock Issued | $103 | $0 | $2 | $42 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2 | $2 | $0 | $1 |
| Financing Cash Flow | $105 | $2 | $2 | $22 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$25 | $28 | -$49 | $8 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $82 | $54 | $101 | $95 |
| End Cash | $57 | $82 | $52 | $103 |
| Free Cash Flow | -$101 | -$119 | $192 | -$54 |